Balaxi Pharmaceuticals Ltd (BALAXI) Stock Price & News

BALAXI:NSE

Balaxi Pharmaceuticals Ltd

₹22.77

+1.92%

(+0.43) 1D

Nov 9, 3:30:00 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for BALAXI...

Open

₹22.64

High

₹23.00

Low

₹21.85

Mkt. cap

1.24B

Avg. vol.

21.04K

Volume

16.63K

P/E ratio

51.50

52-wk high

₹42.74

52-wk low

₹15.20

EPS

₹0.44

No. of employees

500

Open

₹22.64

High

₹23.00

Low

₹21.85

Mkt. cap

1.24B

Avg. vol.

21.04K

Volume

16.63K

P/E ratio

51.50

52-wk high

₹42.74

52-wk low

₹15.20

EPS

₹0.44

No. of employees

500

Related stocks

ORIENTTECH

Orient Technologies Ltd

Blue Coast Hotels Ltd

₹21.50

-0.37%

BONLON

Bonlon Industries Ltd

₹33.66

-3.19%

News stories

From web sources and news partners

bloomingbit

33 minutes ago

Nvidia Falls 4.3% as S&P 500 Rises 2.3% in Rare Divergence Last Seen 17 Years Ago

BigGo Finance

1 hour ago

Wall Street Roars Back: Dow Jumps 1,106 Points as Crude Slides and Chip Stocks Rebound, but Nvidia Breaks Ranks

MarketWatch

46 minutes ago

Dow sees its third 1,000-point swing in four days. Why the volatility isn’t over yet.

hngnews.com

1 hour ago

S&P 500 jumps to its biggest gain since April as oil prices slump, clawing back some of last week's rout

About Balaxi Pharmaceuticals Ltd

CEO-

Employees500

Founded1942

Headquarters-

SectorHealth Care

IndustryHealth care provider

Websitebalaxipharma.in

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	561.75M	725.42M	707.14M	806.82M
Cost of goods sold	290.29M	417.35M	414.90M	431.74M
Cost of revenue	290.29M	417.35M	414.90M	431.74M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	259.77M	277.18M	291.02M	328.46M
Operating expense	264.62M	282.77M	297.48M	336.94M
Total operating expenses	554.91M	700.12M	712.38M	768.68M
Operating income	6.84M	25.30M	-5.25M	38.14M
Other non operating income	15.85M	957.00K	18.30M	-9.92M
EBT including unusual items	13.77M	16.10M	14.03M	20.89M
EBT excluding unusual items	13.77M	16.10M	12.99M	20.89M
Income tax expense	11.68M	13.05M	7.90M	7.92M
Effective tax rate	84.82%	81.05%	56.31%	37.90%
Other operating expenses	-	-	-	-
Net income	2.09M	3.05M	6.13M	12.97M
Net profit margin	0.37%	0.42%	0.87%	1.61%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-8.92M	-10.16M	-9.90M	-7.33M
Net interest expenses	-8.92M	-10.16M	-9.90M	-7.33M
Depreciation and amortization charges	4.84M	5.60M	6.46M	8.48M
EBITDA	11.58M	29.57M	-328.75K	43.06M
Gain or loss from assets sale	-	-	-	-

Ask anything